Literature DB >> 376721

Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.

D Boraschi, M S Meltzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 376721

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  22 in total

1.  Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization.

Authors:  Elizabeth F Redente; Lori D Dwyer-Nield; Daniel T Merrick; Komal Raina; Rajesh Agarwal; William Pao; Pamela L Rice; Kenneth R Shroyer; Alvin M Malkinson
Journal:  Am J Pathol       Date:  2010-04-29       Impact factor: 4.307

2.  Differences in susceptibility of inbred mice to Bacillus anthracis.

Authors:  S L Welkos; T J Keener; P H Gibbs
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

3.  The effect of adherence on the in vitro induction of cytocidal activity by macrophages.

Authors:  A Friedman; D I Beller
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

4.  Genetic complementation of defects in vaccine-induced immunity against Schistosoma mansoni in P- and A-strain inbred mice.

Authors:  R Correa-Oliveira; S L James; A Sher
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

5.  Activation of macrophages for microbicidal and tumoricidal effector functions by soluble factors from EL-4, a continuous T cell line.

Authors:  C A Nacy; S L James; W R Benjamin; J J Farrar; W T Hockmeyer; M S Meltzer
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

6.  Production of mouse lymphotoxin by phytohemagglutinin-stimulated spleen cells requires two cell fractions.

Authors:  R R Aksamit; E J Leonard
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Macrophages in resistance to rickettsial infection: strains of mice susceptible to the lethal effects of Rickettsia akari show defective macrophage Rickettsicidal activity in vitro.

Authors:  C A Nacy; M S Meltzer
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Macrophage-activating factor extracted from mycoplasmas.

Authors:  M Takema; S Oka; K Uno; S Nakamura; H Arita; K Tawara; K Inaba; S Muramatsu
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

9.  Rapid killing of actinomycin D-treated tumour cells by mononuclear phagocytes: reactivity in mouse strains with defective classical tumour cytotoxicity.

Authors:  F Collota; L Bersani; N Polentarutti; A Mantovani
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

10.  Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae.

Authors:  S L James; P C Natovitz; W L Farrar; E J Leonard
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.